OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

RecruitingOBSERVATIONAL
Enrollment

490

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

September 15, 2032

Study Completion Date

September 15, 2034

Conditions
Breast Cancer Stage ITriple Negative Breast Cancer (TNBC)
Interventions
DRUG

Adjuvant chemotherapy

adjuvant chemotherapy according to local/ national guidelines

OTHER

No adjuvant chemotherapy

no adjuvant chemotherapy

Trial Locations (28)

6162 BG

NOT_YET_RECRUITING

Zuyderland Medisch Centrum, Sittard-Geleen

7500 KA

RECRUITING

Medical spectrum Twente, Enschede

Unknown

NOT_YET_RECRUITING

Noordwest Ziekenhuisgroep, Alkmaar

NOT_YET_RECRUITING

Flevoziekenhuis, Almere Stad

RECRUITING

Meander Medisch Centrum, Amersfoort

RECRUITING

Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam

RECRUITING

Rijnstate, Arnhem

RECRUITING

Amphia ziekenhuis, Breda

RECRUITING

Deventer Ziekenhuis, Deventer

RECRUITING

Ziekenhuis Gelderse Vallei, Ede

RECRUITING

Catharina Ziekenhuis, Eindhoven

RECRUITING

Jeroen Bosch ziekenhuis, Eindhoven

RECRUITING

St. Jansdal, Harderwijk

RECRUITING

Ziekenhuisgroep Twente, Hengelo

RECRUITING

Tergooi ziekenhuizen, Hilversum

RECRUITING

Spaarne Gasthuis, Hoofddorp

NOT_YET_RECRUITING

Dijklander ziekenhuis, Hoorn

NOT_YET_RECRUITING

LUMC, Leiden

NOT_YET_RECRUITING

MUMC, Maastricht

RECRUITING

St. Antonius ziekenhuis, Nieuwegein

RECRUITING

Franciscus Gasthuis & Vlietland, Schiedam

RECRUITING

Haaglanden Medisch Centrum, The Hague

NOT_YET_RECRUITING

VieCuri Medisch Centrum voor Noord-Limburg, Venlo

RECRUITING

Isala, Zwolle

1066 CX

RECRUITING

Antoni van Leeuwenhoek, Amsterdam

8934 AD

NOT_YET_RECRUITING

MCL, Leeuwarden

6225GA

NOT_YET_RECRUITING

Radboud UMC, Nijmegen

3015CE

NOT_YET_RECRUITING

Erasmus Medical Center Cancer Institute, Rotterdam

All Listed Sponsors
collaborator

Maarten van de Weijden Foundation

UNKNOWN

collaborator

AVL Foundation

UNKNOWN

lead

The Netherlands Cancer Institute

OTHER